Jakarta province clocked the highest daily COVID-19 cases in Indonesia on Tuesday at 6,391, according to the COVID-19 Task Force.
As of 12 p.m. local time on Tuesday, West Java had recorded 4,249 cases, Banten 2,463 cases, East Java 760 cases, and Bali 715 cases, according to data provided by the COVID-19 Task Force.
These additions took the national tally of daily COVID-19 cases to 16,021, bringing the total number of positive cases since March 2020 to 4,369,391, the task force said.
Of the 16,021 daily cases of COVID-19, 15,485 patients contracted the virus via local transmission and 536 had a history of overseas travel, it added.
The highest recoveries were recorded in Jakarta at 1,668, followed by West Java (869), East Java (292), Banten (253), and Central Java (47).
On the national scale, the daily recovery rate increased by 3,240, bringing the total to 4,143,694 since the beginning of the pandemic.
Jakarta also recorded the most deaths at 12, followed by West Java (4), Central Java and Bali (3 each), and Lampung (2).
The national death tally stood at 28 on Tuesday, thus bringing the total toll to 144,348.
Currently, Indonesia has 12,753 active COVID-19 patients, or patients who are still undergoing treatment and self-isolation, the task force informed. The total figure for active cases has reached 81,349 so far, it added.
Meanwhile, 12,121 people are suspected to have contracted the infections based on 377,588 specimens tested in laboratory networks throughout Indonesia.
According to spokesperson for the Health Ministry, Siti Nadia Tarmizi, as of Monday (January 31, 2022), the total number of patients infected with the Omicron variant had reached 2,980, comprising 1,039 local transmission cases and 1,601 imported cases.
As many as 340 cases were still under epidemiological investigation to determine the history of transmission, she informed.
The ministry reported that so far, there have been five deaths caused by the Omicron variant. As many as 60 percent of patients who died had not received complete doses of the COVID-19 vaccine, and as many as 63 percent experienced moderate to severe symptoms and required oxygen assistance, it said.
Source: Antara News